miR-195 inhibitor reduces liver oxidative stress injury in type 1 diabetic mice

Abstract

Abstract: Objective To investigate the effects of miR-195 on the expression of Sirt1 and its downstream oxidative stress and mitochondrial apoptosis-related proteins in the liver of type 1 diabetic C57BL/6 mice. Methods Mice were divided into control group (Control group), diabetes group (DM group), and miR-195 inhibitor group (DM+antago group). The DM group model was replicated according to the conventional method, and miR-195 inhibitor (2.5 mg/kg) was transfected into DM + antago group mice. The DM group and the control group were injected with scrambled shRNA (2.5 mg/kg) only as a control.Observe and record the increase and decrease of body weight and blood glucose of mice every week. Take fresh liver tissue, one part is processed and made by HE staining for histopathological observation; the part is used to determine the MDA content and T-SOD activity in liver tissue.RT-qPCR and Western blot were used to detect the mRNA and protein content of related indicators in the liver tissue of the three groups of mice. Results 1)Compared with the control group, the leaflets of the liver tissue in the DM group showed structural disorders, hepatocytes were significantly edema, and the cytoplasm was loose; compared with the DM group, the hematocyte edema in the DM+antago group was reduced. 2)Compared with the control group, miR-195 mRNA expression, MDA content and AcFoxo1/Foxo1 protein expression in the DM group were significantly increased (P＜0.05), while Sirt1, Foxo1 mRNA and protein expression, and T-SOD activity were significantly reduced (P＜0.05); Compared with the DM group, miR-195 mRNA expression, MDA content and AcFoxo1/Foxo1 protein expression in the DM + antago group decreased significantly (P＜0.05), while Sirt1, Foxo1 mRNA and protein expression, and T-SOD activity were all Significantly increased (P＜0.05). Conclusions The expression of miR-195 is increased in liver oxidative stress in type 1 diabetic rats. Sirt1 seems to be potential target of miR-195.

Key words: type 1 diabetes, miR-195, silent information regulator 1, oxidative stress, apoptosis

CLC Number:

R587.1

HU Su-qin, WANG Sheng-kai, WU Hang-fei, ZHENG Jing-yu, LI Jian-min. miR-195 inhibitor reduces liver oxidative stress injury in type 1 diabetic mice[J]. Basic & Clinical Medicine, 2020, 40(6): 811-816.

References

[1]Marshall KD, Klutho PJ, Song L, et al. The novel cyclophilin-D-interacting protein FASTKD1 protects cells against oxidative stress-induced cell death[J]. Am J Physiol Cell Physiol,2019,317:584-599.
[2]Zheng D, Yu Y, Li M, et al. Inhibition of microRNA 195 prevents apoptosis and multiple-organ injury in mouse models of sepsis[J]. J Infect Dis, 2016, 213: 1661-1670.
[3]Liu X, Zhao H, Luo C, et al. Acetaminophen responsive miR-19b modulates Sirt1/Nrf2 signaling pathway in drug-induced hepatotoxicity[J]. Toxicol Sci,2019, 170:476-488.
[4]Sui M, Chen G, Mao X, et al. Gegen qinlian decoction ameliorates hepatic insulin resistance by silent information regulator1 (Sirt1)-dependent deacetylation of forkhead box O1 (FOXO1)[J]. Med Sci Monit,2019,25:8544-8553.
[5]Wang Y, Chen J, Kong W, et al.Regulation of Sirt3/Foxo1 signaling pathway in rats with non-alcoholic steatohepatitis by salvianolic acid B[J]. Arch Med Res, 2017,48:506-512.
[6]Ye F, Li X, Li F, et al.Cyclosporin a protects against lead neurotoxicity through inhibiting mitochondrial permeability transition pore opening in nerve cells[J]. Neurotoxicology,2016,57:203-213.
[7]Hermans MP. Diabetes and the endothelium[J]. Acta Clin Belg,2007, 62: 97-101.
[8]Bedi O, Aggarwal S, Trehanpati N,et al. Molecular and pathological events involved in the pathogenesis of diabetes-associated nonalcoholic fatty liver disease[J].J Clin Exp Hepatol, 2019,9:607-618.
[9]Herrera BM, Lockstone HE, Taylor JM, et al.Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes[J].Diabetologia, 2010,53: 1099-1109.
[10]Zhu H, Yang Y, Wang Y, et al. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1[J].Cardiovasc Res,2011,92:75-84.
[11]Yang Y, Hou H, Haller EM, et al.Suppression of Foxo1 activity by FHL2 through SIRT1-mediated deacetylation[J].EMBO J,2005, 24: 1021-1032.
[12]Shen M, Cao Y, Jiang Y, et al. Melatonin protects mouse granulosa cells against oxidative damage by inhibiting Foxo1-mediated autophagy:implication of an antioxidation-independent mechanism[J]. Redox Biol, 2018,18: 138-157.
[13]Baines CP, Kaiser RA, Purcell NH, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death[J]. Nature,2005,434:658-662.
[14]Zhou F, Yang Y, Xing D, et al. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis[J]. FEBS J,2011,278:403-413.

[1]	LUO Menglin, ZHENG Feng, JI Xinyao, QI Caihong, XIAO Yuheng, NIU Changchun. Fluid shear promotes apoptosis of glomerular endothelial cells by activation of Piezo 1 [J]. Basic & Clinical Medicine, 2024, 44(9): 1236-1242.
[2]	PENG Qingyi, XU Lingling. Research progress on the type 1 diabetes induced sarcopenia [J]. Basic & Clinical Medicine, 2024, 44(8): 1189-1193.
[3]	WANG Tingting, WEI Huan, YANG Yongli, ZHOU Xian, HU Yang. Nervous protection provided by notoginsenoside Rg1 in rat model with Alzheimer′s disease [J]. Basic & Clinical Medicine, 2024, 44(8): 1094-1100.
[4]	GAO Chao, ZHANG Runhan, WANG Wei, ZHAO Manting, JIAO Yan, LI Zhe. Effect of artesunate on neuroinflammation in depressed mouse model by regulating cGAS-STING signaling pathway [J]. Basic & Clinical Medicine, 2024, 44(8): 1126-1132.
[5]	YU Dongling, MO Shaoe, FU Wen, CHEN Shi, XIE Chouqin, LAN Yuyan. Inhibition of sigma-1 receptor reduces DRG cell apoptosis of rats with neuropathic pain [J]. Basic & Clinical Medicine, 2024, 44(8): 1101-1106.
[6]	GAO Yinjie, TONG Anli. Mechanisms of cell death and proliferation of aldosterone-producing adenoma [J]. Basic & Clinical Medicine, 2024, 44(6): 758-762.
[7]	LI Jinping, LIU Hanqing, YANG Quanhui. Change of cell cycle in rat spleen after severe abdominal infection [J]. Basic & Clinical Medicine, 2024, 44(6): 828-832.
[8]	GONG Jintao, LI Jianwei, LI Yuheng, LI Qian, ZHAO Chunhua. Bone marrow-derived mesenchymal stem cells relieve the adverse effects of simulated microgravity on mouse cerebral cortex [J]. Basic & Clinical Medicine, 2024, 44(6): 772-778.
[9]	YANG Hanyi, NING Jiayi, WANG Xiaolan, ZHANG Yimeng, XIE Tingke, CHEN Yixuan, HAN Jing. Melatonin inhibits H₂O₂-induced oxidative stress and apoptosis marker protein expression in human umbilical vein endothelial cells [J]. Basic & Clinical Medicine, 2024, 44(5): 645-650.
[10]	WANG Rui, LI Rui, LI Yunlong, ZHANG Yuping, YU Kang, LIU Yanping. Research progress of strontium and pregnancy and pregnancy diseases [J]. Basic & Clinical Medicine, 2024, 44(4): 428-433.
[11]	YANG Chunsheng, WANG Tianxing, ZHANG Tiecheng, WU Hengmin, WANG Baolan. Effects of biological clock gene Bmal1 on the expression of cell cycle-associated genes in chondrocytes [J]. Basic & Clinical Medicine, 2024, 44(4): 496-502.
[12]	YANG Kaifei, ZHU Jingge, ZHANG Yangyang, ZHAO Junguo, GAO Yuyue, HU Huanhuan, JI Guojie. Effect of sorafenib induced apoptosis and autophagy on drug resistance in HeLa cells [J]. Basic & Clinical Medicine, 2024, 44(4): 467-473.
[13]	LI Na, LI Tao, YANG Dongli, YAO Yuan. Honokiol inhibits the proliferation of human adipose-derived mesenchymal stem cells [J]. Basic & Clinical Medicine, 2024, 44(4): 483-488.
[14]	ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin. Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib [J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
[15]	AN Qi, QI Guangzhao, HAN Chao. Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(3): 333-338.